Ozempic Wegovy Weight Loss - Search News

FDA, Ozempic and weight loss

Axios on MSN · 13h

Ozempic and Wegovy shortage ends, setting up weight loss drug showdown

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared Friday. Why it matters: That's good news for Novo Nordisk (whose stock rose 5% Friday) and potentially bad news for Hims & Hers (which fell 26%).

CNN on MSN · 19h

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

The Associated Press on MSN · 12h

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro is approved for diabetes. They use the same active ingredient, tirzepatide.

23hon MSN

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

2d

No more needles? Startups are testing patches to deliver weight-loss drugs and other medications.

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

2d

Hotdogs and motorways: The ripples created by Denmark's Ozempic and Wegovy boom

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

1don MSN

Betty Crocker and Slim Jim's makers' latest target: Ozempic users

Conagra and General Mills are among food companies offering special options for people on GLP-1 drugs, but the products may ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results